Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists

A series of 33 novel, mostly chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives has been synthesized and investigated in radioligand binding assays at the high-affinity adenosine receptor (AR) subtypes A1 and A2a. The compounds can be envisaged as adenine and hypoxanthine analogs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1996-06, Vol.39 (13), p.2482-2491
Hauptverfasser: Müller, Christa E, Geis, Uli, Grahner, Bettina, Lanzner, Wolfgang, Eger, Kurt
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2491
container_issue 13
container_start_page 2482
container_title Journal of medicinal chemistry
container_volume 39
creator Müller, Christa E
Geis, Uli
Grahner, Bettina
Lanzner, Wolfgang
Eger, Kurt
description A series of 33 novel, mostly chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives has been synthesized and investigated in radioligand binding assays at the high-affinity adenosine receptor (AR) subtypes A1 and A2a. The compounds can be envisaged as adenine and hypoxanthine analogs lacking the nitrogen in the 7-position (7-deazaadenines and 7-deazahypoxanthines). 7-Deazaadenines were much more potent than 7-deazahypoxanthines at AR with A1AR affinities in the low-nanomolar range, extraordinarily high selectivity for the rat brain A1AR versus the A2aAR (several thousandfold), and high stereoselectivity (up to 96-fold). Pyrimido[4,5-b]indoles were more potent A1AR antagonists compared to pyrrolo[2,3-d]pyrimidines. Compound 34a (APEPI) is one of the most potent and most selective non-xanthine A1AR antagonists known to date (K i = 2.8 nM, >2000-fold A1-selective). A new class of very potent A1AR antagonists has been identified, namely, 2-phenyl-7-deazaadenines bearing a substituent at the exocyclic amino group (N4-substituted pyrrolo[2,3-d]pyrimidines). (R)-N-(1-Phenylethyl)-4-amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3-d]pyrimidine (DPEAP, 17a) showed a K i value of 6.7 nM at A1AR and >4000-fold A1 selectivity. Different binding modes are postulated for the N4-substituted 4-aminopyrrolo[2,3-d]pyrimidines (e.g., 17a) and the 7-substituted derivatives (e.g., 1a), based on a comparison of steric, electronic, and hydrophobic properties of the two classes of compounds. Water solubility and lipophilicity have been determined for selected compounds. 4-Amino-5,6-dimethyl-2-(3-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidine (4a) showed the highest water solubility/A1AR affinity ratio of 368 in the present series, over 2000-fold A1 selectivity, and 64-fold stereoselectivity (R > S). Therefore, 4a should be an interesting compound for in vivo evaluation.
doi_str_mv 10.1021/jm960011w
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78118152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78118152</sourcerecordid><originalsourceid>FETCH-LOGICAL-a218t-84b95cc55be8ac1f0cfa69ab8827dc72d9f4881eea001c5a188f3c940d76fc2e3</originalsourceid><addsrcrecordid>eNo9ks9uEzEQhy0EKmnhwAMg7QF6yoLt_efltgqEogYRtUUcqspyvLON04292N7C3jjClSfhmfokeJUoJ2v8-2YsfxqEXhD8hmBK3m62ZY4xIT8eoQnJKI5ThtPHaIIxpTHNafIUHTu3wRgnhCZH6IjlJUnTbIL-zdbKijZaDtaa1lzTaRLXN91g1VbVSkMkdD2GY2mu02kWr26Urk0L0Xuw6l54dQ_u3cOvP9Glt730vYWH338rGe6VH6ILaANitFurzkWmiZbGg_bT6EzdrtshNIEF46CFsQOiisRVDdq48e0LkNB5Y6NKe3FrtHLePUNPGtE6eL4_T9DX-Yer2Vm8-PLx06xaxIIS5mOWrspMyixbAROSNFg2Ii_FijFa1LKgddmkjBEAEbzJTBDGmkSWKa6LvJEUkhN0upvbWfO9B-f5VjkJbSs0mN7xghHCgusAvtyD_WoLNe-CK2EHvlcc8lf7XDgp2sYKLZU7YAkhZVmkAYt3WPgk_DzEwt7xvEiKjF8tLzlZfD7_dj7P-Tzwr3e8kI5vTG91sMEJ5uNC8MNCJP8B6JqqnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78118152</pqid></control><display><type>article</type><title>Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Müller, Christa E ; Geis, Uli ; Grahner, Bettina ; Lanzner, Wolfgang ; Eger, Kurt</creator><creatorcontrib>Müller, Christa E ; Geis, Uli ; Grahner, Bettina ; Lanzner, Wolfgang ; Eger, Kurt</creatorcontrib><description>A series of 33 novel, mostly chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives has been synthesized and investigated in radioligand binding assays at the high-affinity adenosine receptor (AR) subtypes A1 and A2a. The compounds can be envisaged as adenine and hypoxanthine analogs lacking the nitrogen in the 7-position (7-deazaadenines and 7-deazahypoxanthines). 7-Deazaadenines were much more potent than 7-deazahypoxanthines at AR with A1AR affinities in the low-nanomolar range, extraordinarily high selectivity for the rat brain A1AR versus the A2aAR (several thousandfold), and high stereoselectivity (up to 96-fold). Pyrimido[4,5-b]indoles were more potent A1AR antagonists compared to pyrrolo[2,3-d]pyrimidines. Compound 34a (APEPI) is one of the most potent and most selective non-xanthine A1AR antagonists known to date (K i = 2.8 nM, &gt;2000-fold A1-selective). A new class of very potent A1AR antagonists has been identified, namely, 2-phenyl-7-deazaadenines bearing a substituent at the exocyclic amino group (N4-substituted pyrrolo[2,3-d]pyrimidines). (R)-N-(1-Phenylethyl)-4-amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3-d]pyrimidine (DPEAP, 17a) showed a K i value of 6.7 nM at A1AR and &gt;4000-fold A1 selectivity. Different binding modes are postulated for the N4-substituted 4-aminopyrrolo[2,3-d]pyrimidines (e.g., 17a) and the 7-substituted derivatives (e.g., 1a), based on a comparison of steric, electronic, and hydrophobic properties of the two classes of compounds. Water solubility and lipophilicity have been determined for selected compounds. 4-Amino-5,6-dimethyl-2-(3-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidine (4a) showed the highest water solubility/A1AR affinity ratio of 368 in the present series, over 2000-fold A1 selectivity, and 64-fold stereoselectivity (R &gt; S). Therefore, 4a should be an interesting compound for in vivo evaluation.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm960011w</identifier><identifier>PMID: 8691445</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenine - analogs &amp; derivatives ; Animals ; Biological and medical sciences ; Cerebral Cortex - metabolism ; Computer Graphics ; Corpus Striatum - metabolism ; Hypoxanthines - chemical synthesis ; Hypoxanthines - chemistry ; Hypoxanthines - pharmacology ; Indoles - chemical synthesis ; Indoles - chemistry ; Indoles - pharmacology ; Magnetic Resonance Spectroscopy ; Medical sciences ; Miscellaneous ; Molecular Conformation ; Molecular Structure ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Protein Binding ; Purinergic P1 Receptor Antagonists ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Radioligand Assay ; Rats ; Receptors, Purinergic P1 - metabolism ; Solubility ; Stereoisomerism ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1996-06, Vol.39 (13), p.2482-2491</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm960011w$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm960011w$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3119974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8691445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Müller, Christa E</creatorcontrib><creatorcontrib>Geis, Uli</creatorcontrib><creatorcontrib>Grahner, Bettina</creatorcontrib><creatorcontrib>Lanzner, Wolfgang</creatorcontrib><creatorcontrib>Eger, Kurt</creatorcontrib><title>Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of 33 novel, mostly chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives has been synthesized and investigated in radioligand binding assays at the high-affinity adenosine receptor (AR) subtypes A1 and A2a. The compounds can be envisaged as adenine and hypoxanthine analogs lacking the nitrogen in the 7-position (7-deazaadenines and 7-deazahypoxanthines). 7-Deazaadenines were much more potent than 7-deazahypoxanthines at AR with A1AR affinities in the low-nanomolar range, extraordinarily high selectivity for the rat brain A1AR versus the A2aAR (several thousandfold), and high stereoselectivity (up to 96-fold). Pyrimido[4,5-b]indoles were more potent A1AR antagonists compared to pyrrolo[2,3-d]pyrimidines. Compound 34a (APEPI) is one of the most potent and most selective non-xanthine A1AR antagonists known to date (K i = 2.8 nM, &gt;2000-fold A1-selective). A new class of very potent A1AR antagonists has been identified, namely, 2-phenyl-7-deazaadenines bearing a substituent at the exocyclic amino group (N4-substituted pyrrolo[2,3-d]pyrimidines). (R)-N-(1-Phenylethyl)-4-amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3-d]pyrimidine (DPEAP, 17a) showed a K i value of 6.7 nM at A1AR and &gt;4000-fold A1 selectivity. Different binding modes are postulated for the N4-substituted 4-aminopyrrolo[2,3-d]pyrimidines (e.g., 17a) and the 7-substituted derivatives (e.g., 1a), based on a comparison of steric, electronic, and hydrophobic properties of the two classes of compounds. Water solubility and lipophilicity have been determined for selected compounds. 4-Amino-5,6-dimethyl-2-(3-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidine (4a) showed the highest water solubility/A1AR affinity ratio of 368 in the present series, over 2000-fold A1 selectivity, and 64-fold stereoselectivity (R &gt; S). Therefore, 4a should be an interesting compound for in vivo evaluation.</description><subject>Adenine - analogs &amp; derivatives</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - metabolism</subject><subject>Computer Graphics</subject><subject>Corpus Striatum - metabolism</subject><subject>Hypoxanthines - chemical synthesis</subject><subject>Hypoxanthines - chemistry</subject><subject>Hypoxanthines - pharmacology</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - chemistry</subject><subject>Indoles - pharmacology</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Molecular Conformation</subject><subject>Molecular Structure</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Binding</subject><subject>Purinergic P1 Receptor Antagonists</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Receptors, Purinergic P1 - metabolism</subject><subject>Solubility</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9ks9uEzEQhy0EKmnhwAMg7QF6yoLt_efltgqEogYRtUUcqspyvLON04292N7C3jjClSfhmfokeJUoJ2v8-2YsfxqEXhD8hmBK3m62ZY4xIT8eoQnJKI5ThtPHaIIxpTHNafIUHTu3wRgnhCZH6IjlJUnTbIL-zdbKijZaDtaa1lzTaRLXN91g1VbVSkMkdD2GY2mu02kWr26Urk0L0Xuw6l54dQ_u3cOvP9Glt730vYWH338rGe6VH6ILaANitFurzkWmiZbGg_bT6EzdrtshNIEF46CFsQOiisRVDdq48e0LkNB5Y6NKe3FrtHLePUNPGtE6eL4_T9DX-Yer2Vm8-PLx06xaxIIS5mOWrspMyixbAROSNFg2Ii_FijFa1LKgddmkjBEAEbzJTBDGmkSWKa6LvJEUkhN0upvbWfO9B-f5VjkJbSs0mN7xghHCgusAvtyD_WoLNe-CK2EHvlcc8lf7XDgp2sYKLZU7YAkhZVmkAYt3WPgk_DzEwt7xvEiKjF8tLzlZfD7_dj7P-Tzwr3e8kI5vTG91sMEJ5uNC8MNCJP8B6JqqnQ</recordid><startdate>19960621</startdate><enddate>19960621</enddate><creator>Müller, Christa E</creator><creator>Geis, Uli</creator><creator>Grahner, Bettina</creator><creator>Lanzner, Wolfgang</creator><creator>Eger, Kurt</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19960621</creationdate><title>Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists</title><author>Müller, Christa E ; Geis, Uli ; Grahner, Bettina ; Lanzner, Wolfgang ; Eger, Kurt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a218t-84b95cc55be8ac1f0cfa69ab8827dc72d9f4881eea001c5a188f3c940d76fc2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adenine - analogs &amp; derivatives</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - metabolism</topic><topic>Computer Graphics</topic><topic>Corpus Striatum - metabolism</topic><topic>Hypoxanthines - chemical synthesis</topic><topic>Hypoxanthines - chemistry</topic><topic>Hypoxanthines - pharmacology</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - chemistry</topic><topic>Indoles - pharmacology</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Molecular Conformation</topic><topic>Molecular Structure</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Binding</topic><topic>Purinergic P1 Receptor Antagonists</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Receptors, Purinergic P1 - metabolism</topic><topic>Solubility</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Müller, Christa E</creatorcontrib><creatorcontrib>Geis, Uli</creatorcontrib><creatorcontrib>Grahner, Bettina</creatorcontrib><creatorcontrib>Lanzner, Wolfgang</creatorcontrib><creatorcontrib>Eger, Kurt</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Müller, Christa E</au><au>Geis, Uli</au><au>Grahner, Bettina</au><au>Lanzner, Wolfgang</au><au>Eger, Kurt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-06-21</date><risdate>1996</risdate><volume>39</volume><issue>13</issue><spage>2482</spage><epage>2491</epage><pages>2482-2491</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A series of 33 novel, mostly chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives has been synthesized and investigated in radioligand binding assays at the high-affinity adenosine receptor (AR) subtypes A1 and A2a. The compounds can be envisaged as adenine and hypoxanthine analogs lacking the nitrogen in the 7-position (7-deazaadenines and 7-deazahypoxanthines). 7-Deazaadenines were much more potent than 7-deazahypoxanthines at AR with A1AR affinities in the low-nanomolar range, extraordinarily high selectivity for the rat brain A1AR versus the A2aAR (several thousandfold), and high stereoselectivity (up to 96-fold). Pyrimido[4,5-b]indoles were more potent A1AR antagonists compared to pyrrolo[2,3-d]pyrimidines. Compound 34a (APEPI) is one of the most potent and most selective non-xanthine A1AR antagonists known to date (K i = 2.8 nM, &gt;2000-fold A1-selective). A new class of very potent A1AR antagonists has been identified, namely, 2-phenyl-7-deazaadenines bearing a substituent at the exocyclic amino group (N4-substituted pyrrolo[2,3-d]pyrimidines). (R)-N-(1-Phenylethyl)-4-amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3-d]pyrimidine (DPEAP, 17a) showed a K i value of 6.7 nM at A1AR and &gt;4000-fold A1 selectivity. Different binding modes are postulated for the N4-substituted 4-aminopyrrolo[2,3-d]pyrimidines (e.g., 17a) and the 7-substituted derivatives (e.g., 1a), based on a comparison of steric, electronic, and hydrophobic properties of the two classes of compounds. Water solubility and lipophilicity have been determined for selected compounds. 4-Amino-5,6-dimethyl-2-(3-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidine (4a) showed the highest water solubility/A1AR affinity ratio of 368 in the present series, over 2000-fold A1 selectivity, and 64-fold stereoselectivity (R &gt; S). Therefore, 4a should be an interesting compound for in vivo evaluation.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8691445</pmid><doi>10.1021/jm960011w</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1996-06, Vol.39 (13), p.2482-2491
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_78118152
source MEDLINE; American Chemical Society Journals
subjects Adenine - analogs & derivatives
Animals
Biological and medical sciences
Cerebral Cortex - metabolism
Computer Graphics
Corpus Striatum - metabolism
Hypoxanthines - chemical synthesis
Hypoxanthines - chemistry
Hypoxanthines - pharmacology
Indoles - chemical synthesis
Indoles - chemistry
Indoles - pharmacology
Magnetic Resonance Spectroscopy
Medical sciences
Miscellaneous
Molecular Conformation
Molecular Structure
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Protein Binding
Purinergic P1 Receptor Antagonists
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Radioligand Assay
Rats
Receptors, Purinergic P1 - metabolism
Solubility
Stereoisomerism
Structure-Activity Relationship
title Chiral Pyrrolo[2,3-d]pyrimidine and Pyrimido[4,5-b]indole Derivatives:  Structure−Activity Relationships of Potent, Highly Stereoselective A1-Adenosine Receptor Antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T00%3A17%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chiral%20Pyrrolo%5B2,3-d%5Dpyrimidine%20and%20Pyrimido%5B4,5-b%5Dindole%20Derivatives:%E2%80%89%20Structure%E2%88%92Activity%20Relationships%20of%20Potent,%20Highly%20Stereoselective%20A1-Adenosine%20Receptor%20Antagonists&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=M%C3%BCller,%20Christa%20E&rft.date=1996-06-21&rft.volume=39&rft.issue=13&rft.spage=2482&rft.epage=2491&rft.pages=2482-2491&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm960011w&rft_dat=%3Cproquest_pubme%3E78118152%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78118152&rft_id=info:pmid/8691445&rfr_iscdi=true